Correlation Between Vicore Pharma and Mendus AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vicore Pharma and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vicore Pharma and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vicore Pharma Holding and Mendus AB, you can compare the effects of market volatilities on Vicore Pharma and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vicore Pharma with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vicore Pharma and Mendus AB.

Diversification Opportunities for Vicore Pharma and Mendus AB

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Vicore and Mendus is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vicore Pharma Holding and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and Vicore Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vicore Pharma Holding are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of Vicore Pharma i.e., Vicore Pharma and Mendus AB go up and down completely randomly.

Pair Corralation between Vicore Pharma and Mendus AB

Assuming the 90 days trading horizon Vicore Pharma Holding is expected to generate 0.79 times more return on investment than Mendus AB. However, Vicore Pharma Holding is 1.27 times less risky than Mendus AB. It trades about -0.03 of its potential returns per unit of risk. Mendus AB is currently generating about -0.31 per unit of risk. If you would invest  800.00  in Vicore Pharma Holding on September 1, 2024 and sell it today you would lose (16.00) from holding Vicore Pharma Holding or give up 2.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vicore Pharma Holding  vs.  Mendus AB

 Performance 
       Timeline  
Vicore Pharma Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Mendus AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mendus AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mendus AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Vicore Pharma and Mendus AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vicore Pharma and Mendus AB

The main advantage of trading using opposite Vicore Pharma and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vicore Pharma position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.
The idea behind Vicore Pharma Holding and Mendus AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments